易生活控股(00223.HK):中商惠民要求延長還款時間表
易生活控股(00223.HK)公布,截至去年12月31日,集團已向中商惠民收取3,280萬元人民幣(下同),而尚未償還結餘為1,720萬元,中商惠民要求延長該還款時間表,公司管理層即時與中商惠民之代表展開磋商,務求盡早結清餘下結餘。
於1月5日應集團要求,中商惠民就餘下結餘提供還款時間表,第1-11期於今年首十一月最後一日到期,每月還款150萬元,而最後一期到期日為12月31日,金額為70萬元加任何截至最後還款日之累計滯納金。時間表尚未獲集團接納獲同意,公司管理層將與中商惠民之代表就餘下結餘之還款時間表之條款作進一步磋商,務求就還款時間表達成公平合理且符合公司及股東利益之較佳條款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.